Most founders I speak to know they need to raise capital. Fewer have thought carefully about how – specifically, which instrument they use to bring that capital in. That matters more than people realise, because the choice affects your cap table, your compliance burden, your timeline, and sometimes your relationship with existing investors.
Two instruments come up most in these conversations: rights issue and private placement. Both result in fresh share issuance. Both dilute someone. But they operate on entirely different logic.
The Rights Issue: Shareholders First
A rights issue gives existing shareholders the first shot at buying new shares – in proportion to what they already hold.
If you own 10% of the company today, you get the right to subscribe to 10% of the new shares being issued. You can exercise that right or let it lapse. But the company cannot bypass you and go straight to someone else. That pre-emptive structure is the whole point.
The governing provision is Section 62(1)(a) of the Companies Act, 2013. For listed companies, SEBI layered regulations sit on top of that.
Here’s how it plays out in practice: a company with 10 lakh shares outstanding announces a 1:4 rights issue – one new share for every four already held. A shareholder with 40,000 shares gets the right to buy 10,000 more at the issue price. If they don’t take it up, their percentage holding drops once others subscribe. If they do, their stake stays intact.
Listed infrastructure companies, banks, and large manufacturing groups use this route fairly often – mainly when they want to raise meaningful capital without freezing out the existing investor base.
The Private Placement: Targeted, Negotiated, Faster
Private placement works differently. The company picks who it wants to bring in – a venture fund, a strategic partner, a family office, a high-net-worth individual – and issues shares directly to that investor through a bilateral negotiation.
No rights ratio. No obligation to approach existing shareholders first (unless your shareholders’ agreement says otherwise). No public subscription window.
Section 42 of the Companies Act governs this. One important constraint: you can approach a maximum of 200 persons per class of securities in a financial year, excluding QIBs and employees under ESOPs.
For listed companies, this route is called a preferential allotment under SEBI’s ICDR Regulations. Same underlying concept, heavier disclosure and approval requirements.
In practice: a startup with a 50 lakh share cap table raises ₹15 crore from a single venture fund through a private placement at a negotiated price. New shares go to the fund. Existing shareholders dilute. Deal closes once the board resolution is passed and Form PAS-3 is filed within 15 days of allotment.
Where They Actually Diverge
Who Gets to Subscribe
Rights issues are for existing shareholders – all of them, in proportion to current holding. The company doesn’t get to be selective.
Private placements are exactly the opposite. The company chooses the investors. New entrants are fine. A subset of existing shareholders is fine. The only limit is the 200-person cap.
What Happens to Existing Shareholders
In a rights issue, existing shareholders who exercise their rights don’t dilute at all. Their percentage stays put. Dilution only happens if they consciously choose not to participate.
In a private placement, there’s no such protection. Everyone who isn’t part of the placement gets diluted. That’s why PE and VC term sheets almost always include pro-rata rights and anti-dilution provisions – the contractual protections compensate for what the statutory structure doesn’t provide.
How Pricing Works
For rights issues in listed companies, SEBI sets a pricing floor tied to average market prices over a defined period. For unlisted companies, the price needs to be at or above fair value – which means a valuation report from a registered valuer.
For private placements in listed companies (preferential allotments), SEBI’s formula applies: the higher of the average weekly high/low of the closing price for the preceding 26 weeks or 2 weeks before the relevant board meeting date.
For unlisted companies issuing to Indian residents, Rule 11UA of the Income Tax Act governs minimum pricing. If foreign investors are involved, FEMA pricing guidelines come in – and valuation must be done using internationally accepted pricing methods.
This is where I’d push back on any founder who thinks pricing is secondary. Section 56(2)(viib) taxes a company if it issues shares above fair market value – the excess is treated as income. Section 56(2)(x) can tax the recipient if shares are issued below fair value. These aren’t theoretical risks. They come up in tax assessments.
Compliance Load
Rights issues carry more process weight. You’re dealing with every eligible shareholder – NRIs, retail investors, institutional holders. The offer letter goes to all of them. There’s a subscription window (15–30 days for unlisted companies). Renunciation rights usually apply. RoC filings follow.
Private placements are leaner on process but have their own formalities: special resolution, offer letter to identified persons, Form PAS-3 within 15 days of allotment, separate records for each placement. Listed companies add SEBI disclosures, stock exchange filings, and lock-in requirements.
Timeline
A rights issue for a listed company can take months by the time you account for board meetings, shareholder notifications, the subscription window, and allotment. Even for unlisted companies, getting all shareholders to respond takes time.
Private placements move faster once the commercial negotiation is done. If documentation is in order, allotment can happen within a week of passing the special resolution.
When Each One Gets Used
Companies typically reach for a rights issue when they want to raise large capital while giving existing investors the option to stay fully in, or when promoter dilution is a concern, or when they’re listed and need to be transparent with retail shareholders.
Private placements come up when the company is onboarding a specific investor who brings strategic value beyond just capital, when speed matters, when the company is unlisted with a concentrated cap table, or when the terms being negotiated – board rights, liquidation preferences, conversion mechanics – can only be set in a bilateral conversation.
Comparison at a Glance
| Parameter | Rights Issue | Private Placement |
| Who subscribes | Existing shareholders only | Selected investors (new or existing) |
| Proportionality | Yes – based on current holding | No requirement |
| Dilution protection | Yes, if rights are exercised | None for non-participants |
| Governing law | Section 62(1)(a), Companies Act 2013 | Section 42, Companies Act 2013 |
| Listed company route | SEBI rights issue regulations | Preferential allotment under ICDR |
| Pricing basis | Fair value / SEBI floor | Rule 11UA / FEMA / SEBI formula |
| Valuation mandatory | Yes | Yes |
| Subscriber cap | None (all eligible shareholders) | 200 per class of securities per year |
| Speed | Slower | Faster |
| Typical use case | Listed companies, large capital raises | Startups, PE/VC, strategic deals |
Questions That Come Up Often
Can a company exclude certain shareholders from a rights issue?
No – not without specific cause. The entire design of a rights issue is proportional access to all existing shareholders. Some structures allow rights to be renounced or offered on a different basis, but standard exclusions aren’t available.
For a startup, which route makes more sense?
Private placement, almost always. Early-stage companies don’t typically have a large dispersed shareholder base that needs rights protection. And the ability to negotiate valuation, governance terms, and liquidation preferences bilaterally is something rights issues simply don’t accommodate.
Does every private placement need shareholder approval?
Yes. Section 42 requires a special resolution, valid for one year from passing.
Can you do both in the same year?
Yes, subject to applicable regulations. They’re not mutually exclusive instruments.
The Valuation Question
Whether you’re doing a rights issue or a private placement, you need a valuation – not as a formality, but as the document that justifies your share price to the tax department, the RoC, SEBI (if applicable), your auditors, and potentially a future investor running due diligence.
For rights issues, mispricing hurts somebody. Too low, and non-participating shareholders lose more than they should. Too high, and the issue falls flat.
For private placements, the tax exposure under Sections 56(2)(viib) and 56(2)(x) is real. And for FEMA transactions, the pricing guidelines are non-negotiable – a valuation that doesn’t use internationally accepted methods won’t hold up.
The valuation report needs to be documented, methodology-driven, and defensible. It’s not something that should be reverse-engineered from a price you’ve already agreed to with an investor.
